Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

EJMCR. 2020; 4(4): 130-133


Seromucinous hamartoma of the sinonasal tract: report of a rare case

Henrique Furlan Pauna, Eulalia Sakano, Alexandre Caixeta Guimaraes.




Abstract
Cited by 0 Articles

Background: The sinonasal tract is anatomically complex and it houses a wide variety of inflammatory, benign, and malignant lesions. While inflammatory polyps are easily recognized by the pathologists, the nasal hamartoma still poorly understood. Seromucinous hamartoma have only been recognized over the past few years. They are a diagnostic challenge, needing to be distinguished from low-grade adenocarcinomas, and are of interest because most of the basic questions about their pathophysiology remain unanswered.
Case presentation: We present a case of seromucinous hamartoma with features that partly expand the morphologic spectrum of these lesions, in a 50-year-old man. We also discuss the differential diagnosis and review the literature to compare our findings with previously reported cases with the aim of better understanding this interesting entity.
Conclusion: Seromucinous hamartoma is a condition that may mimic several different sinonasal tumors, and further discussion and research are necessary to evaluate its full long-term impact.

Key words: Sinonasal tract, tumor, salivary gland, nasal obstruction, exocrine glands, case report






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.